glp 1 drugs blindness Can Ozempic-like Cause Blindness? Their Ophthalmic Complications Explained #DoctorSpeak, New diabetes and weight-loss drugs like Semaglutide and Tirzepatide (Commonly known as Ozempic, Wegovy) The protective role of GLP-1

Bariatric surgery carries perioperative risk (mortality 0.03-0.2%), but for patients with BMI 35+ and comorbidities, the long-term health risks of untreated obesity typically exceed surgical risks

The results showed that at 52 weeks or 104 weeks, patients with liraglutide (1.8 or 1.2 mg/day) or glimepiride (8 mg/day) had no significant difference in average total bone mass change compared with baseline

Cision PR Newswire

I really appreciate your team's work here, and I can't wait to dig into the data

, Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials, Endocrinol

It was optional